tirzepatide and aspirin What are the contraindications to (Mounjaro) Semaglutide (Ozempic, Glucagon-like peptide-1 receptor agonist)? Tirzepatide outperformed semaglutide weight-loss drug

Mounjaro is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycaemic control in adults with T2DM.

This is especially beneficial when commercially available medications do not suit a patients specific requirements, such as allergies or dosage preferences

Results: The relative proportion of full length (FL) and fragmented forms (f1 and f3) of plasma IGFBP-2 were similar between men and women

To understand why delivery matters, visit our educational page on Liposomal Delivery

,

In recent years, the effects of GLP-1 agonists/analogues on the CNS have gained relevance due to emerging evidence supporting the neuroprotective effects of these molecules